4-Morpholinepropanamine, beta-methyl-N-(3-phenyl-5-isoxazolyl)-(86684-22-2)
- Name: 4-Morpholinepropanamine, beta-methyl-N-(3-phenyl-5-isoxazolyl)-
- Synonyms:4-Morpholinepropanamine, beta-methyl-N-(3-phenyl-5-isoxazolyl)-
- Molecular Formula:C17H23 N3 O2
- Molecular Weight:0
- CAS Registry Number:86684-22-2
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.86684-22-2 4-Morpholinepropanamine, beta-methyl-N-(3-phenyl-5-isoxazolyl)-
Assay:99% Appearance:powder or liquid Package:according to customer requirements Storage:store in dry dark and ventilated place Transportation:By Sea/Air/Courier Application:It is an important raw material.
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.86684-22-2 4-Morpholinepropanamine, beta-methyl-N-(3-phenyl-5-isoxazolyl)-
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.86684-22-2 4-Morpholinepropanamine, beta-methyl-N-(3-phenyl-5-isoxazolyl)-
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:4-Morpholinepropanamine, beta-methyl-N-(3-phenyl-5-isoxazolyl)-
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
Other Product
- 5343-58-8/2-benzyl-2-ethyl-hexanoic acid
- 9001-84-7/Phospholipase A2
- 68954-09-6/ETHYLENE/BUTYLENE COPOLYMER, MONOHYDROXY TERMINATED
- 15625-89-5/Trimethylolpropane triacrylate
- 17176-43-1/betaine choline [R-(R*,R*)]-tartrate
- 67905-32-2/tetradecanolate aluminium
- 92201-10-0/Zirconium, C4-10-fatty acid naphthenate complexes
- 100678-32-8/Cibenzoline succinate
- 30424-39-6/Naphthalenediazonium
- 73637-08-8/4-{(E)-[(2-methoxyethyl)imino]methyl}-N,N-dimethylaniline
- 101997-45-9/3-chloro-5-methoxy-4-[2-(3-methylpiperidin-1-yl)ethoxy]aniline hydrochloride
- 68490-68-6/2-Methylimidazole, compd. with 1,3,5-triazine-2,4,6(1H,3H,5H)-trione
- 34415-56-0/(2beta,4beta,15R)-2-hydroxy-15-methyl-4,10-cyclolycopodan-5-one
- 69816-26-8/1-[(2,2-dimethyl-4-phenyl-3,4-dihydro-2H-chromen-7-yl)oxy]-3-(4-methylpiperazin-1-yl)propan-2-ol hydrochloride
- 197969-51-0/Polyquaternium-47
- 2198-51-8/4-[bis(2-hydroxyethyl)amino]phenol
- 464-07-3/3,3-DIMETHYL-2-BUTANOL
- 86684-22-2/4-Morpholinepropanamine, beta-methyl-N-(3-phenyl-5-isoxazolyl)-
- 523-14-8/Yohimban-17-one
- 59921-94-7/1-[4-(4-fluorophenyl)-4-oxobutyl]pyrrolidin-2-one
- 32041-50-2/5-Chloro-3-[(2-thioxo-4-oxothiazolidine-5-yl)azo]-2-hydroxybenzenesulfonic acid
- 68555-25-9/o-Cresol, cresylic acid, tung oil, formaldehyde resin
- 131-08-8/Sodium anthraquinone-2-sulfonate
- 91744-56-8/Glycerides, mixed C8-10 and succinyl
- 3983-45-7/FENCHLORPHOS-OXON
- 10173-84-9/2-(4-methoxybenzoyl)-1-benzofuran-3(2H)-one
- 17122-69-9/N-(3,4-Dimethylphenyl)-2-(hydroxyimino)acetamide
- 13005-07-7/1,4-Benzenedicarboxamide,N1,N4-bis[4-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenyl]-, hydrochloride(1:2)
- 116963-86-1/Azuleno[5,4-b]furan-2,8-dione,3a,4,5,6,6a,7-hexahydro-3a-hydroxy-1,6,9-trimethyl-, (3aR,6R,6aS)-
- 74626-45-2/N-{[(6aS)-1,2,9,10-tetramethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-3-yl]methyl}acetamide hydrochloride